TY  - JOUR
AU  - Callejas Rubio, José Luis
AU  - Luna Del Castillo, Juan de Dios
AU  - de la Hera Fernández, Javier
AU  - Guirao Arrabal, Emilio
AU  - Colmenero Ruiz, Manuel
AU  - Ortego Centeno, Norberto
PY  - 2020
DO  - 10.1016/j.medcli.2020.04.018
UR  - http://hdl.handle.net/10668/15731
T2  - Medicina clinica
AB  - Cytokine storm syndrome (CSS) is a serious complication of COVID-19 patients. Treatment is tocilizumab. The use of glucocorticoids (GC) is controversial. In other very similar CSS, such as macrophage activation syndrome (MAS) and hemophagocytic...
LA  - en
KW  - Coronavirus COVID-19
KW  - Cytokine release synddrome
KW  - Hemofagocítico
KW  - Hemophagocytic
KW  - Síndrome de liberación de citocinas
KW  - Adrenal Cortex Hormones
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - Betacoronavirus
KW  - COVID-19
KW  - Coronavirus Infections
KW  - Cytokine Release Syndrome
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Intubation, Intratracheal
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Pandemics
KW  - Pneumonia, Viral
KW  - Retrospective Studies
KW  - SARS-CoV-2
TI  - Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection.
T2  - Eficacia de los pulsos de corticoides en pacientes con síndrome de liberación de citocinas inducido por infección por SARS-CoV-2.
TY  - research article
VL  - 155
ER  -